REICH KRISTIAN (Chief Scientific Officer) sold 0.0% of their position (1.10K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $22.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/29/2026ACC: 0001213900-26-082804
Officer· Chief Scientific Officer
Since Apr 2022
-1.10K
Net shares
Net seller
$22.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.10K disposed
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Indirect
Shares
−1.10K
Price / share
$20.00
Trade value
$22K
% of position
0.0%
7/27/2026
2.71M→2.71M
Total
Net shares
−1.10K
Net value
-$22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Indirect | 7/27/2026 | S · Sale | −1.10K | $20.00 | $22K | 0.0% | 2.71M | 2.71M |
| Total | −1.10K | -$22K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A ordinary shares, par value $0.0001 per share
DirectShares owned35.39K
Total
35.39K direct35.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A ordinary shares, par value $0.0001 per share | 35.39K | Direct |
| Total | 35.39K | 35.39K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported